SMS Lifesciences India Limited

NSEI:SMSLIFE Rapporto sulle azioni

Cap. di mercato: ₹3.0b

SMS Lifesciences India Crescita futura

Future criteri di controllo 0/6

Al momento non disponiamo di una copertura analitica sufficiente per prevedere la crescita e il fatturato di SMS Lifesciences India.

Informazioni chiave

n/a

Tasso di crescita degli utili

n/a

Tasso di crescita dell'EPS

Pharmaceuticals crescita degli utili17.7%
Tasso di crescita dei ricavin/a
Rendimento futuro del capitale proprion/a
Copertura analitica

None

Ultimo aggiornamenton/a

Aggiornamenti recenti sulla crescita futura

Nessun aggiornamento

Recent updates

Earnings Working Against SMS Lifesciences India Limited's (NSE:SMSLIFE) Share Price Following 25% Dive

Nov 14
Earnings Working Against SMS Lifesciences India Limited's (NSE:SMSLIFE) Share Price Following 25% Dive

Improved Earnings Required Before SMS Lifesciences India Limited (NSE:SMSLIFE) Stock's 58% Jump Looks Justified

Aug 27
Improved Earnings Required Before SMS Lifesciences India Limited (NSE:SMSLIFE) Stock's 58% Jump Looks Justified

Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?

Aug 01
Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?

SMS Lifesciences India Limited (NSE:SMSLIFE) Stock Catapults 27% Though Its Price And Business Still Lag The Market

Jun 13
SMS Lifesciences India Limited (NSE:SMSLIFE) Stock Catapults 27% Though Its Price And Business Still Lag The Market

SMS Lifesciences India (NSE:SMSLIFE) Use Of Debt Could Be Considered Risky

Feb 10
SMS Lifesciences India (NSE:SMSLIFE) Use Of Debt Could Be Considered Risky

There's Reason For Concern Over SMS Lifesciences India Limited's (NSE:SMSLIFE) Massive 30% Price Jump

Jan 05
There's Reason For Concern Over SMS Lifesciences India Limited's (NSE:SMSLIFE) Massive 30% Price Jump

Should Shareholders Reconsider SMS Lifesciences India Limited's (NSE:SMSLIFE) CEO Compensation Package?

Sep 23
Should Shareholders Reconsider SMS Lifesciences India Limited's (NSE:SMSLIFE) CEO Compensation Package?

SMS Lifesciences India (NSE:SMSLIFE) Is Paying Out A Dividend Of ₹1.50

Sep 07
SMS Lifesciences India (NSE:SMSLIFE) Is Paying Out A Dividend Of ₹1.50

SMS Lifesciences India (NSE:SMSLIFE) Has Affirmed Its Dividend Of ₹1.50

Aug 24
SMS Lifesciences India (NSE:SMSLIFE) Has Affirmed Its Dividend Of ₹1.50

SMS Lifesciences India (NSE:SMSLIFE) Will Pay A Dividend Of ₹1.50

Sep 16
SMS Lifesciences India (NSE:SMSLIFE) Will Pay A Dividend Of ₹1.50

SMS Lifesciences India (NSE:SMSLIFE) Will Pay A Dividend Of ₹1.50

Sep 02
SMS Lifesciences India (NSE:SMSLIFE) Will Pay A Dividend Of ₹1.50

SMS Lifesciences India (NSE:SMSLIFE) Takes On Some Risk With Its Use Of Debt

Jun 03
SMS Lifesciences India (NSE:SMSLIFE) Takes On Some Risk With Its Use Of Debt

With EPS Growth And More, SMS Lifesciences India (NSE:SMSLIFE) Is Interesting

May 13
With EPS Growth And More, SMS Lifesciences India (NSE:SMSLIFE) Is Interesting

SMS Lifesciences India's (NSE:SMSLIFE) Solid Profits Have Weak Fundamentals

Nov 23
SMS Lifesciences India's (NSE:SMSLIFE) Solid Profits Have Weak Fundamentals

Is Now The Time To Put SMS Lifesciences India (NSE:SMSLIFE) On Your Watchlist?

Jun 21
Is Now The Time To Put SMS Lifesciences India (NSE:SMSLIFE) On Your Watchlist?

Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?

Feb 22
Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?

SMS Lifesciences India Limited's (NSE:SMSLIFE) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Jan 04
SMS Lifesciences India Limited's (NSE:SMSLIFE) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Insider Buying: The SMS Lifesciences India Limited (NSE:SMSLIFE) MD & Executive Director Just Bought 19% More Shares

Nov 27
Insider Buying: The SMS Lifesciences India Limited (NSE:SMSLIFE) MD & Executive Director Just Bought 19% More Shares

Does SMS Lifesciences India (NSE:SMSLIFE) Have A Healthy Balance Sheet?

Nov 24
Does SMS Lifesciences India (NSE:SMSLIFE) Have A Healthy Balance Sheet?

In questa sezione di solito presentiamo le proiezioni di crescita dei ricavi e degli utili basate sulle stime di consenso degli analisti professionisti per aiutare gli investitori a capire la capacità della società di generare profitti. Tuttavia, poiché SMS Lifesciences India non ha fornito dati sufficienti sul passato e non ha previsioni degli analisti, i suoi utili futuri non possono essere calcolati in modo affidabile estrapolando i dati passati o utilizzando le previsioni degli analisti.

Si tratta di una situazione piuttosto rara, dato che il 97% delle società coperte da SimplyWall St dispone di dati finanziari passati.

Previsioni di crescita degli utili e dei ricavi

NSEI:SMSLIFE - Stime future degli analisti e dati finanziari passati (INR Millions )
DataRicaviGuadagniFlusso di cassa liberoLiquidità dell'operazioneAvg. Numero di analisti
9/30/20243,169219192335N/A
6/30/20243,239179N/AN/AN/A
3/31/20243,0609134243N/A
12/31/20232,79749N/AN/AN/A
9/30/20233,12146-176120N/A
6/30/20233,07967N/AN/AN/A
3/31/20233,156115-339147N/A
12/31/20223,475189N/AN/AN/A
9/30/20223,505172-6246N/A
6/30/20223,558247N/AN/AN/A
3/31/20223,501253-624-112N/A
12/31/20213,366213N/AN/AN/A
9/30/20213,118216-82364N/A
6/30/20212,871147N/AN/AN/A
3/31/20212,656136-4352N/A
12/31/20202,291106N/AN/AN/A
9/30/20202,09176-16361N/A
6/30/20202,23779N/AN/AN/A
3/31/20202,608102-88145N/A
12/31/20193,220127N/AN/AN/A
9/30/20193,970188N/AN/AN/A
6/30/20194,098195N/AN/AN/A
3/31/20193,77917856300N/A
12/31/20182,997146N/AN/AN/A
9/30/20182,697119N/AN/AN/A
6/30/20182,31585N/AN/AN/A
3/31/20182,13065N/A80N/A
12/31/20172,14872N/AN/AN/A
6/30/20172,03490N/AN/AN/A
3/31/20172,159129N/A197N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: Dati insufficienti per determinare se la crescita degli utili prevista SMSLIFE è superiore al tasso di risparmio ( 6.7% ).

Guadagni vs Mercato: Dati insufficienti per determinare se si prevede che gli utili di SMSLIFE cresceranno più velocemente del mercato Indian

Guadagni ad alta crescita: Dati insufficienti per determinare se si prevede che gli utili di SMSLIFE cresceranno in modo significativo nei prossimi 3 anni.

Ricavi vs Mercato: Dati insufficienti per determinare se si prevede che i ricavi di SMSLIFE cresceranno più rapidamente del mercato Indian.

Ricavi ad alta crescita: Dati insufficienti per determinare se si prevede che i ricavi di SMSLIFE cresceranno più rapidamente di 20% all'anno.


Previsioni di crescita dell'utile per azione


Rendimento futuro del capitale proprio

ROE futuro: Dati insufficienti per determinare se il Return on Equity di SMSLIFE è previsto essere elevato tra 3 anni


Scoprire le aziende in crescita